معرفی
Dr. Vibhu Jha is an Assistant Professor at the Institute of Cancer Therapeutics, part of the School of Pharmacy & Medical Sciences at the University of Bradford. He holds a PhD from the University of Pisa (Italy) with a focus on computational drug discovery, followed by postdoctoral research at the University of Gothenburg (Sweden) and the University of Dundee (UK). His expertise lies in computational modeling techniques (e.g., molecular docking, machine learning) for anticancer drug design, targeting pathways like 1C metabolism and EGFR-driven resistance.
Education:
- B.Pharm, Chhattisgarh Swami Vivekananda Technical University (2008–2012)
- M.S. Pharm (Medicinal Chemistry), National Institute of Pharmaceutical Education and Research (2013–2015)
- PhD, University of Pisa (2017–2021)
Research Focus: Dr. Jha’s work integrates AI/ML with conventional computational methods to study protein interactions (e.g., protein-ligand, protein-DNA) and develop inhibitors against cancer targets. Key projects include:
- Targeting MTHFD2/SHMT2 in breast/colorectal cancers
- Designing dual EGFR/ACK1 inhibitors for lung cancer
- Developing topoisomerase-HDAC dual inhibitors
Awards: 8 awards (specific names not listed in available texts).
Advising & Collaboration: Supervised master’s projects at the University of Gothenburg. Collaborates with Prof. Raj Kumar (Central University of Punjab), Prof. Leif Eriksson (University of Gothenburg), and Prof. Tiziano Tuccinardi (University of Pisa). Active in computational drug design, AI-driven predictive models, and structure-based drug design.
Labs & Teams: Based at the Institute of Cancer Therapeutics, Bradford. Engaged in cross-disciplinary teams focused on computational oncology and translational drug discovery.
